Funder
National Center for Advancing Translational Sciences
Advancing a Healthier Wisconsin Endowment
National Institutes of Health
National Cancer Institute
Subject
Cancer Research,Oncology,Oral Surgery
Reference33 articles.
1. American Cancer Society. Cancer Statistics Center. Accessed April 2, 2023. https://cancerstatisticscenter.cancer.org/.
2. Final Report of a Prospective Randomized Trial to Evaluate the Dose-Response Relationship for Postoperative Radiation Therapy and Pathologic Risk Groups in Patients With Head and Neck Cancer;Rosenthal;Int J Radiat Oncol Biol Phys,2017
3. Avelumab plus standard-of-care chemoradiotherapy versus chemoradiotherapy alone in patients with locally advanced squamous cell carcinoma of the head and neck: a randomised, double-blind, placebo-controlled, multicentre, phase 3 trial;Lee;Lancet Oncol,2021
4. LBA35 Avelumab-cetuximab-radiotherapy versus standards of care in patients with locally advanced squamous cell carcinoma of head and neck (LA-SCCHN): Randomized phase III GORTEC-REACH trial;Bourhis;Ann Oncol,2021
5. LBA38 Pembrolizumab versus cetuximab, concomitant with radiotherapy (RT) in locally advanced head and neck squamous cell carcinoma (LA-HNSCC): Results of the GORTEC 2015–01 “PembroRad” randomized trial;Bourhis;Ann Oncol,2020
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献